|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
*
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5462856A
(en)
|
1990-07-19 |
1995-10-31 |
Bunsen Rush Laboratories, Inc. |
Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
|
|
US5440021A
(en)
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
|
US5314992A
(en)
|
1991-11-25 |
1994-05-24 |
Trustees Of Dartmouth College |
Lipocortin-1 receptor protein and its uses
|
|
US5817310A
(en)
|
1991-12-02 |
1998-10-06 |
Cor Therapeutics, Inc. |
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
JP3664176B2
(ja)
|
1992-11-10 |
2005-06-22 |
ジェネンテック・インコーポレーテッド |
Ｃ−ｃ ｃｋｒ−１，ｃ−ｃケモカインレセプター
|
|
ES2118372T3
(es)
|
1992-11-17 |
1998-09-16 |
Icos Corp |
Nuevos receptores siete transmembrana v28.
|
|
US5652133A
(en)
|
1993-01-28 |
1997-07-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor
|
|
DE59403818D1
(de)
|
1993-02-20 |
1997-10-02 |
Hoechst Ag |
Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
|
|
US5739103A
(en)
|
1993-11-12 |
1998-04-14 |
Dana-Farber Cancer Institute |
Chemokine N-terminal deletion mutations
|
|
JP3532570B2
(ja)
|
1994-01-13 |
2004-05-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
哺乳類単球化学誘引物質タンパク質レセプター
|
|
DE4408212A1
(de)
|
1994-03-11 |
1995-09-14 |
Bayer Ag |
5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
|
|
US6180773B1
(en)
|
1994-04-30 |
2001-01-30 |
Wolf-Georg Forssmann |
Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3
|
|
US6806061B1
(en)
|
1995-01-19 |
2004-10-19 |
Children's Medical Center Corporation |
G protein-coupled receptor gene and methods of use therefor
|
|
US6537764B1
(en)
|
1995-01-19 |
2003-03-25 |
Children's Medical Center Corporation |
Method of identifying inhibitors of C—C chemokine receptor 3
|
|
GB9501683D0
(en)
|
1995-01-27 |
1995-03-15 |
Glaxo Group Ltd |
Substances and their uses
|
|
AU2766395A
(en)
|
1995-06-05 |
1996-12-24 |
Human Genome Sciences, Inc. |
Human g-protein receptor hgber32
|
|
US6743594B1
(en)
|
1995-06-06 |
2004-06-01 |
Human Genome Sciences, Inc. |
Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
|
|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
JPH10510719A
(ja)
|
1995-06-06 |
1998-10-20 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
ヒトｇタンパク質ケモカインレセプターｈｄｇｎｒ１０
|
|
US7265201B1
(en)
|
1995-06-23 |
2007-09-04 |
Millennium Pharmaceuticals, Inc. |
Human chemotactic cytokine
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
ATE262346T1
(de)
|
1995-11-30 |
2004-04-15 |
Us Gov Health & Human Serv |
C-c chemokine die die infektion mit retoviren verhindern
|
|
US6512103B1
(en)
|
1995-12-08 |
2003-01-28 |
Schering Corporation |
Mammalian chemokine reagents
|
|
US6265184B1
(en)
|
1995-12-20 |
2001-07-24 |
Icos Corporation |
Polynucleotides encoding chemokine receptor 88C
|
|
WO1997025340A1
(en)
|
1996-01-11 |
1997-07-17 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor hsatu68
|
|
AU1834197A
(en)
|
1996-01-30 |
1997-08-22 |
National Institutes Of Health, The |
Cells expressing both human cd4 and cxcr4
|
|
ATE428785T1
(de)
|
1996-03-01 |
2009-05-15 |
Euroscreen Sa |
Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren
|
|
EP0906339A2
(en)
|
1996-03-27 |
1999-04-07 |
NG, Gordon, Y., K. |
Receptor and transporter antagonists
|
|
US6344545B1
(en)
|
1996-06-14 |
2002-02-05 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
|
US6107019A
(en)
|
1996-06-14 |
2000-08-22 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
|
EP0915969A4
(en)
|
1996-04-02 |
2002-04-17 |
Progenics Pharm Inc |
SUPPRESSION OF CD4 + CELL INFECTION BY HIV
|
|
JP2000510690A
(ja)
|
1996-04-26 |
2000-08-22 |
インサイト・ファーマスーティカルズ・インコーポレイテッド |
哺乳類混合リンパ球受容体、ケモカイン受容体（ｍｍｌｒ―ｃｃｒ）
|
|
US5939320A
(en)
|
1996-05-20 |
1999-08-17 |
New York University |
G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
|
|
US6258527B1
(en)
|
1996-05-20 |
2001-07-10 |
The Aaron Diamond Aids Research Center |
Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
|
|
AU3375697A
(en)
|
1996-05-28 |
1998-01-05 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Cc chemokine receptor 5, antibodies thereto, transgenic animals
|
|
US5961976A
(en)
|
1996-06-03 |
1999-10-05 |
United Biomedical, Inc. |
Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV
|
|
DK0910659T3
(da)
|
1996-06-03 |
2006-11-27 |
United Biomedical Inc |
Antistoffer mod et kompleks af CD4 og et kemokin-receptordomæne og anvendelse deraf mod HIV-infektioner
|
|
EP0956044A4
(en)
|
1996-06-14 |
2005-01-05 |
Progenics Pharm Inc |
USES OF A CHEMOKIN RECEPTOR TO INHIBIT HIV-1 INFECTION
|
|
AU3505397A
(en)
|
1996-06-25 |
1998-01-14 |
Trustees Of The University Of Pennsylvania, The |
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
|
|
US5994515A
(en)
|
1996-06-25 |
1999-11-30 |
Trustees Of The University Of Pennsylvania |
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
|
|
WO1998000535A2
(en)
|
1996-06-28 |
1998-01-08 |
Dana-Farber Cancer Institute |
Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection
|
|
US5928881A
(en)
|
1996-07-11 |
1999-07-27 |
Smithkline Beecham Corporation |
Method of identifying agonists and antagonist for CC-CKR5 receptor
|
|
JP2000516210A
(ja)
|
1996-07-12 |
2000-12-05 |
ロイコサイト，インコーポレーテッド |
ケモカインレセプターアンタゴニストとその使用方法
|
|
AU4055897A
(en)
|
1996-08-08 |
1998-02-25 |
Aaron Diamond Aids Research Center, The |
Hiv coreceptor mutants
|
|
US6057102A
(en)
|
1996-08-08 |
2000-05-02 |
The Aaron Diamond Aids Research Center |
HIV coreceptor mutants
|
|
ATE360689T1
(de)
|
1996-09-10 |
2007-05-15 |
Kocher Theodor Inst |
Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
|
|
US6388055B1
(en)
|
1996-10-03 |
2002-05-14 |
Smithkline Beecham Corporation |
Mouse CC-CKR5 receptor polypeptide
|
|
WO1998015569A1
(en)
|
1996-10-09 |
1998-04-16 |
Dana-Farber Cancer Institute |
Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection
|
|
US5939538A
(en)
|
1996-10-25 |
1999-08-17 |
Immusol Incorporated |
Methods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNA
|
|
US6528625B1
(en)
|
1996-10-28 |
2003-03-04 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR5 antibodies and kits comprising same
|
|
CA2270132A1
(en)
|
1996-11-06 |
1998-05-14 |
Sequenom, Inc. |
Dna diagnostics based on mass spectrometry
|
|
WO1998025605A1
(en)
|
1996-12-13 |
1998-06-18 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
US5962462A
(en)
|
1996-12-13 |
1999-10-05 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
WO1998025604A1
(en)
|
1996-12-13 |
1998-06-18 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
AU5522498A
(en)
|
1996-12-13 |
1998-07-03 |
Merck & Co., Inc. |
Substituted aryl piperazines as modulators of chemokine receptor activity
|
|
US5919776A
(en)
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
AU5812498A
(en)
|
1996-12-20 |
1998-07-17 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
AR011057A1
(es)
|
1997-01-08 |
2000-08-02 |
Smithkline Beecham Corp |
Uso de bis-acridinas sustituidas y compuestos afines para la preparacion de medicamentos y dichos compuestos
|
|
US5798206A
(en)
|
1997-01-10 |
1998-08-25 |
New York Blood Center |
Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor
|
|
AU6133098A
(en)
|
1997-01-21 |
1998-08-07 |
Merck & Co., Inc. |
3,3-disubstituted piperidines as modulators of chemokine receptor activity
|
|
RU2126048C1
(ru)
|
1997-01-28 |
1999-02-10 |
Институт молекулярной генетики РАН |
Способ определения генетической устойчивости обследуемых к инфицированию вирусом иммунодефицита человека первого типа (вич-1)
|
|
WO1998034945A1
(en)
|
1997-02-06 |
1998-08-13 |
Epoch Pharmaceuticals, Inc. |
Targeted modification of the ccr-5 gene
|
|
US6100387A
(en)
|
1997-02-28 |
2000-08-08 |
Genetics Institute, Inc. |
Chimeric polypeptides containing chemokine domains
|
|
US6214540B1
(en)
|
1997-03-26 |
2001-04-10 |
University Of Maryland Biotechnology Institute |
Chemokines that inhibit immunodeficiency virus infection and methods based thereon
|
|
CA2285384C
(en)
|
1997-03-28 |
2012-10-16 |
Epitope, Inc. |
Simultaneous collection of dna and non-nucleic analytes from oral fluids
|
|
IT1291353B1
(it)
|
1997-05-12 |
1999-01-07 |
San Raffaele Centro Fond |
Peptidi con attivita' antivirale
|
|
US6153431A
(en)
|
1997-05-30 |
2000-11-28 |
Fond Mondiale Rech & Prev Sida |
Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
|
|
FR2764387B1
(fr)
|
1997-06-05 |
1999-07-23 |
Centre Nat Rech Scient |
Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
|
|
EP0989802A1
(en)
|
1997-06-23 |
2000-04-05 |
J. David Gladstone Institutes |
Transgenic rabbits expressing cd4 and chemokine receptor
|
|
AU3044697A
(en)
|
1997-06-24 |
1999-01-04 |
Norman Godin |
A composition for specific immunoprotection and method for obtaining said comp osition
|
|
ZA985542B
(en)
|
1997-07-03 |
1999-04-07 |
Smithkline Beecham Corp |
Substituted benzanilides as CCR5 receptor ligands antiinflammatory agents and antiviral agents
|
|
EP1003514A4
(en)
|
1997-07-25 |
2000-10-11 |
Merck & Co Inc |
CYCLIC AMINE MODULATORS OF CHEMOKIN RECEPTORS
|
|
AU8669598A
(en)
|
1997-07-29 |
1999-02-22 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Chemokine receptor ccr8 dna and uses thereof
|
|
US6019979A
(en)
|
1997-08-15 |
2000-02-01 |
The Picower Institute For Medical Research |
Anti-viral treatment with pertussis toxin B oligomer
|
|
EP1009405A4
(en)
|
1997-08-28 |
2001-05-09 |
Merck & Co Inc |
PAYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
|
|
WO1999012416A1
(en)
|
1997-09-09 |
1999-03-18 |
The Trustees Of Columbia University In The City Of New York |
T-independent conjugate-vaccines
|
|
US6204024B1
(en)
|
1997-09-12 |
2001-03-20 |
Akzo Nobel N.V. |
CCR5 RNA transcription based amplification assay
|
|
WO1999014378A2
(en)
|
1997-09-19 |
1999-03-25 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods using interleukin 4 to treat hiv infection
|
|
AR013669A1
(es)
|
1997-10-07 |
2001-01-10 |
Smithkline Beecham Corp |
Compuestos y metodos
|
|
WO1999023253A1
(en)
|
1997-10-30 |
1999-05-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Stromal cell derived factor-1 (sdf-1) and method of use for diagnostic and prognostic indicator of aids pathogenesis
|
|
AU1449499A
(en)
|
1997-10-31 |
1999-05-24 |
Maxygen, Incorporated |
Modification of virus tropism and host range by viral genome shuffling
|
|
EP1037963A4
(en)
|
1997-11-10 |
2004-09-22 |
Univ Columbia |
X-RAY CRYSTAL CONTAINING HIV-1 GP120
|
|
AU1454599A
(en)
|
1997-11-10 |
1999-05-31 |
Dana-Farber Cancer Institute |
Compounds inhibiting cd4-gp120 interaction and uses thereof
|
|
FR2771423A1
(fr)
|
1997-11-21 |
1999-05-28 |
Transgene Sa |
Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible
|
|
WO1999028474A2
(en)
|
1997-12-01 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services |
Chemokine variants and methods of use
|
|
WO1999027939A1
(en)
|
1997-12-04 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
|
|
US6013644A
(en)
|
1997-12-12 |
2000-01-11 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
WO1999032100A2
(en)
|
1997-12-19 |
1999-07-01 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
|
|
EP1059932A1
(en)
|
1997-12-19 |
2000-12-20 |
Immunex Corporation |
Method for reducing susceptibility to hiv infection
|
|
CA2316447C
(en)
|
1997-12-23 |
2009-07-28 |
Fondazione Centro San Raffaele Del Monte Tabor |
Rantes mutants and therapeutic applications thereof
|
|
WO1999036518A1
(en)
|
1998-01-15 |
1999-07-22 |
Btg International Limited |
Ribozymal nucleic acids cleaving ccr5 or cxcr4
|
|
EP1052992A1
(en)
|
1998-02-02 |
2000-11-22 |
Merck & Co., Inc. |
Cyclic amine modulators of chemokine receptor activity
|
|
CA2321962C
(en)
|
1998-02-27 |
2014-07-15 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
G protein-coupled receptor antagonists
|
|
JPH11243960A
(ja)
|
1998-03-06 |
1999-09-14 |
Shionogi & Co Ltd |
ヒトｃｃ型ケモカインエオタキシン３
|
|
US6100087A
(en)
|
1998-03-11 |
2000-08-08 |
City Of Hope |
Ribozymes targeted to human CCR5 mRNA
|
|
US6287805B1
(en)
|
1998-03-20 |
2001-09-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor
|
|
JPH11292795A
(ja)
|
1998-04-02 |
1999-10-26 |
Yamanouchi Pharmaceut Co Ltd |
Ｈｉｖコファクター抑制剤
|
|
WO1999053033A1
(en)
|
1998-04-16 |
1999-10-21 |
Vanderbilt University |
Methods and compositions for high yield production of eukaryotic proteins
|
|
US6399078B1
(en)
|
1998-06-01 |
2002-06-04 |
University Of Maryland Biotechnology Institute |
Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
EP1088108A4
(en)
|
1998-06-23 |
2002-04-17 |
Uab Research Foundation |
Cell-based assay for immunodeficiency virus infectivity and sensitivity
|
|
US6872538B1
(en)
|
1998-07-06 |
2005-03-29 |
Euroscreen S.A. |
High-throughput screening diagnostic and/or dosage method of an agonist and/or an antagonist for a calcium-coupled receptor
|
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
|
PL345713A1
(en)
|
1998-07-28 |
2002-01-02 |
Smithkline Beecham Corp |
Substituted anilide compounds and methods
|
|
CA2338804A1
(en)
|
1998-07-28 |
2000-02-10 |
Smithkline Beecham Corporation |
Propenamides as ccr5 modulators
|
|
US6399656B1
(en)
|
1998-07-28 |
2002-06-04 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
EP0979655A1
(de)
|
1998-08-01 |
2000-02-16 |
Boehringer Mannheim Gmbh |
Mittel zur Behandlung von durch RNA-Viren, wie beispielsweise HIV verursachten Infenktionen
|
|
HK1042706A1
(zh)
|
1998-08-03 |
2002-08-23 |
东卡罗来纳大学 |
低腺苷反义寡核苷酸制剂、组合物、试剂盒及处理
|
|
BR9912732A
(pt)
|
1998-08-03 |
2001-11-27 |
Univ Montana |
Estrutura molecular isolada, vìrus envelopadorecombinante, formilação de vacina, anticorpomonoclonal, anti-soro policlonal, geléia, espuma,creme ou unguento contraceptivo, amostras desangue de mamìfero e de humano, kit, linhagemcelular, processos de tratamento ou deprevenção de infecção por um vìrus em sujeito, detratamento ou de prevenção de infecção por hivem um humano, de inibição de infecção por um vìrusem uma amostra de sangue, de inibição de infecçãopor hiv em uma amostra de sangue humano, dedescontaminação de ferramentas cirúrgicas oudentais, de monitoração de produto de anticorpopara a estrutura molecular, de produção de umimunógeno para uso em uma vacina para otratamento ou a prevenção de infecção por umvìrus, e de produção de um imunólogeno para usoem uma vacina para o tratamento ou a prevençãode infecção por hiv, estrutura reticulada,anticorpo monoclonal para a estrutura, dedescontaminação de ferramentas cirúrgicas oudentais, processo de seleção de uma estruturamolecular para eficácia de vacina, mamìfero,complexo de proteìna isolado, formulação devacina, processos de imunização de um animal paraum vìrus, e de preparação de um complexo deproteìna, células fixadas, processos depurificação de um complexo de proteìna e detratamento de um hospedeiro que tem sidoexposto a um vìrus, ou de prevenção de infecçãode um hospedeiro pelo citado vìrus, e composição.
|
|
EP1104416A2
(en)
|
1998-08-20 |
2001-06-06 |
Takeda Chemical Industries, Ltd. |
Quaternary ammonium salts and their use as anti-hiv agents
|
|
US6475718B2
(en)
|
1998-09-08 |
2002-11-05 |
Schering Aktiengesellschaft |
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
|
|
EP1112362B1
(de)
|
1998-09-10 |
2006-02-08 |
Siffert, Winfried |
GENVERÄNDERUNG IM GEN FÜR DIE G$g(b)3-UNTEREINHEIT DES HUMANEN G-PROTEINS
|
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
|
JP2003523744A
(ja)
|
2000-02-09 |
2003-08-12 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
Ｃｃｒ５に対する抗体
|
|
US6849163B2
(en)
|
2000-02-29 |
2005-02-01 |
Daikin Industries, Ltd. |
Method for producing tetrafluoroethylene
|
|
US20020177552A1
(en)
|
2000-06-09 |
2002-11-28 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US7005503B2
(en)
*
|
2002-02-08 |
2006-02-28 |
Genetastix Corporation |
Human monoclonal antibody against coreceptors for human immunodeficiency virus
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
US20020146415A1
(en)
*
|
2001-04-06 |
2002-10-10 |
Olson William C. |
Methods for inhibiting HIV-1 infection
|
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
WO2003075944A2
(en)
|
2002-03-12 |
2003-09-18 |
Maxygen Aps |
Interferon beta-like molecules for treatment of stroke
|
|
WO2004020468A2
(en)
|
2002-08-28 |
2004-03-11 |
Maxygen Aps |
Interferon beta-like molecules for treatment of cancer
|